Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes

被引:98
作者
Ehrlich, S [1 ]
Infante-Duarte, C [1 ]
Seeger, B [1 ]
Zipp, F [1 ]
机构
[1] Univ Hosp, Charite, Neurosci Res Ctr, Inst Neuroimmunol, D-10098 Berlin, Germany
关键词
B-cell; interferon-beta; monocyte; T cell;
D O I
10.1016/S1043-4666(03)00094-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF/nerve growth factor superfamily that, apart from inducing cell death in susceptible cells, displays immunoregulatory functions influencing, for instance, T cell proliferation. It can be found in two forms: membrane-bound and soluble protein. The regulation of these is still not fully understood. In this study, we have analyzed the regulation of TRAIL surface expression and secretion in human T cells, B cells, and monocytes in response to specific stimuli. T cells, B cells, and monocytes were cultured in the presence of phytohemagglutinin (PHA) + interleukin (IL-2), anti-CD40 + IL-4, and lipopolysaccharide (LPS), respectively. In particular, not only PHA + IL-2 but also LPS were able to induce secretion of soluble TRAIL, but did not enhance the expression of surface-bound TRAIL. Simultaneously, we investigated the effect of the pleiotropic stimulus interferon (IFN)-beta, known to target all leukocyte subsets, on TRAIL. Predominantly, monocytes were affected by IFN-beta, causing both release of soluble TRAIL and upregulation of the surface-bound form. IFN-beta, however, did not cause any upregulation of TRAIL in T cells. Our data serve as a basis to better understand the complex regulation of TRAIL in human peripheral immune cells and might help to clarify the role of the TRAIL system in immunopathology. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:244 / 253
页数:10
相关论文
共 41 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]   The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain [J].
Degli-Esposti, MA ;
Dougall, WC ;
Smolak, PJ ;
Waugh, JY ;
Smith, CA ;
Goodwin, RG .
IMMUNITY, 1997, 7 (06) :813-820
[3]   Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [J].
Fanger, NA ;
Maliszewski, CR ;
Schooley, K ;
Griffith, TS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) :1155-1164
[4]   CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (APO-2L) in haematological malignancies [J].
Fiumara, P ;
Younes, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) :265-274
[5]  
Francis G, 2001, NEUROLOGY, V56, P1628
[6]   Genomic organization and transcriptional regulation of human Apo2/TRAIL gene [J].
Gong, B ;
Almasan, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) :747-752
[7]   SELECTIVE TRIGGERING OF HUMAN T-LYMPHOCYTES AND B-LYMPHOCYTES INVITRO BY POLYCLONAL MITOGENS [J].
GREAVES, M ;
JANOSSY, G ;
DOENHOFF, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1974, 140 (01) :1-18
[8]   Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL [J].
Griffith, TS ;
Wiley, SR ;
Kubin, MZ ;
Sedger, LM ;
Maliszewski, CR ;
Fanger, NA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) :1343-1353
[9]  
Halaas O, 2000, SCAND J IMMUNOL, V51, P244
[10]   Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis [J].
Hilliard, B ;
Wilmen, A ;
Seidel, C ;
Liu, TST ;
Göke, R ;
Chen, YH .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :1314-1319